Skip to content

Study · Animal study (in vivo) · pig · 1991

3 results

[Morphofunctional characteristics of the immunocompetent system in hypotrophy and its correction by thymogen].

Khmel'nitskiĭ OK, Belianin VL, Kotov VA, Liutinskiĭ SI

Arkhiv patologii1 Jan 1991

PMID1793373 (opens in a new tab)PepBankPUB-01793373
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In pigs with hypotrophy, thymogen positively affected the condition, and the effect persisted 230 days after treatment.

    In plain wordsIn pigs with hypotrophy, thymogen positively affected the condition, and the effect persisted 230 days after treatment.

    Peptide
    Thymogen (oglufanide)
    Outcome
    Not applicableCourse of hypotrophy
    Study

    pign: not reported in source

    Hypotrophy
    Outcome group
    Linear growth · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Administration of the synthetic thymic peptide-thymogen to the pigs with symptoms of hypotrophy exerted a positive effect on the course of this pathological condition this resulting from the stimulation of the central and peripheral parts of the immunogenesis.
    1 context sentence
    Summary · context
    230 days after the treatment the positive effect still persisted.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In pigs with hypotrophy, thymogen stimulated central immunogenesis.

    In plain wordsIn pigs with hypotrophy, thymogen stimulated central immune development.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseCentral immunogenesis
    Study

    pign: not reported in source

    Hypotrophy
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Administration of the synthetic thymic peptide-thymogen to the pigs with symptoms of hypotrophy exerted a positive effect on the course of this pathological condition this resulting from the stimulation of the central and peripheral parts of the immunogenesis.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In pigs with hypotrophy, thymogen stimulated peripheral immunogenesis.

    In plain wordsIn pigs with hypotrophy, thymogen stimulated peripheral immune development.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreasePeripheral immunogenesis
    Study

    pign: not reported in source

    Hypotrophy
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Administration of the synthetic thymic peptide-thymogen to the pigs with symptoms of hypotrophy exerted a positive effect on the course of this pathological condition this resulting from the stimulation of the central and peripheral parts of the immunogenesis.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.